BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 34690279)

  • 1. Updates in cutaneous manifestations of systemic vasculitis.
    Elbendary A; Abdel-Halim MRE; Ragab G
    Curr Opin Rheumatol; 2022 Jan; 34(1):25-32. PubMed ID: 34690279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous Manifestations of Medium- and Large-Vessel Vasculitis.
    Chasset F; Francès C
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):452-468. PubMed ID: 28547523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular risk in vasculitis.
    Misra DP; Sharma A; Karpouzas GA; Kitas GD
    Best Pract Res Clin Rheumatol; 2023 Mar; 37(1):101831. PubMed ID: 37302927
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulatory T cells and systemic vasculitis.
    Mirouse A; Cacoub P; Saadoun D
    Curr Opin Rheumatol; 2023 Jan; 35(1):25-30. PubMed ID: 36508306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary manifestations of large, medium, and variable vessel vasculitis.
    Adams TN; Zhang D; Batra K; Fitzgerald JE
    Respir Med; 2018 Dec; 145():182-191. PubMed ID: 30509707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and histopathological spectrum of cutaneous vasculitis in rheumatoid arthritis.
    Chen KR; Toyohara A; Suzuki A; Miyakawa S
    Br J Dermatol; 2002 Nov; 147(5):905-13. PubMed ID: 12410699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Takayasu arteritis and cutaneous necrotizing vasculitis.
    Skaria AM; Ruffieux P; Piletta P; Chavaz P; Saurat JH; Borradori L
    Dermatology; 2000; 200(2):139-43. PubMed ID: 10773704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental Triggers for Vasculitis.
    Katz G; Wallace ZS
    Rheum Dis Clin North Am; 2022 Nov; 48(4):875-890. PubMed ID: 36333001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient reported outcomes in systemic vasculitis.
    Crawshaw H; Wells M; Austin K; Janagan S; Robson JC
    Curr Opin Rheumatol; 2022 Jan; 34(1):33-38. PubMed ID: 34738981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous Manifestations of Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Micheletti RG; Chiesa Fuxench Z; Craven A; Watts RA; Luqmani RA; Merkel PA;
    Arthritis Rheumatol; 2020 Oct; 72(10):1741-1747. PubMed ID: 32419292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nosology of primary vasculitis.
    Jennette JC; Falk RJ
    Curr Opin Rheumatol; 2007 Jan; 19(1):10-6. PubMed ID: 17143090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood-onset Takayasu arteritis presenting as pyoderma gangrenosum-like vasculitic ulceration: Three case reports and a literature review.
    Shen C; Zhao S; Wang B; Shen Y; Xiao Y; Xu Z
    Australas J Dermatol; 2022 May; 63(2):244-247. PubMed ID: 35132609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous vasculitis update: neutrophilic muscular vessel and eosinophilic, granulomatous, and lymphocytic vasculitis syndromes.
    Carlson JA; Chen KR
    Am J Dermatopathol; 2007 Feb; 29(1):32-43. PubMed ID: 17284960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac involvement and cardiovascular risk factors in pediatric primary systemic vasculitides.
    Sener S; Arslanoglu Aydin E; Batu ED
    Clin Rheumatol; 2023 Mar; 42(3):673-686. PubMed ID: 36369404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of systemic vasculitis.
    Ozguler Y; Esatoglu SN; Hatemi G
    Curr Opin Rheumatol; 2024 Jan; 36(1):21-26. PubMed ID: 37800639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cutaneous arteriolitis: A novel cutaneous small vessel vasculitis disorder clinicopathologically different from cutaneous polyarteritis nodosa and cutaneous venulitis.
    Yamamoto T; Chen KR
    J Cutan Pathol; 2020 Sep; 47(9):854-859. PubMed ID: 32338386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neutrophil: A key resourceful agent in immune-mediated vasculitis.
    Aymonnier K; Amsler J; Lamprecht P; Salama A; Witko-Sarsat V
    Immunol Rev; 2023 Mar; 314(1):326-356. PubMed ID: 36408947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous Manifestations Related to COVID-19 Immune Dysregulation in the Pediatric Age Group.
    Larenas-Linnemann D; Luna-Pech J; Navarrete-Rodríguez EM; Rodríguez-Pérez N; Arias-Cruz A; Blandón-Vijil MV; Del Rio-Navarro BE; Estrada-Cardona A; Onuma-Takane E; Pozo-Beltrán CF; Valencia-Herrera AM; Ortiz-Aldana FI; Toledo-Bahena ME
    Curr Allergy Asthma Rep; 2021 Feb; 21(2):13. PubMed ID: 33630167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inflammatory muscle involvement in systemic vasculitis: A systematic review.
    Conticini E; d'Alessandro M; Al Khayyat SG; D'Alessandro R; D'Ignazio E; Pata AP; Vallifuoco G; Falsetti P; Baldi C; Bardelli M; Gentileschi S; Fabiani C; Mazzei MA; Guarnieri A; Bargagli E; Cantarini L; Frediani B
    Autoimmun Rev; 2022 Mar; 21(3):103029. PubMed ID: 34971804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous necrotizing vasculitis complicating Takayasu's arteritis with a review of cutaneous manifestations.
    Mousa AR; Marafie AA; Dajani AI
    J Rheumatol; 1985 Jun; 12(3):607-10. PubMed ID: 2864443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.